PO.BCS02.05 · 生物信息与计算
一种从明场图像中提取全面单细胞生物物理特征谱的深度学习框架
A deep learning framework for extracting comprehensive single-cell biophysical profiles from brightfield images
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
单细胞生物物理测量(包括质量、体积、密度和形态)提供了对细胞状态高度综合的读数。我们此前已证明,这些测量能够快速评估肿瘤细胞的药物反应和免疫细胞的功能适应性。作为一项通过CLIA认证、报告周转期为两天的工作流程的一部分,该方法能够在多种实体瘤恶性肿瘤中提供具有临床可操作性的决策支持,并预测免疫检查点阻断的反应。然而,这些多参数测量所需的复杂仪器设备和专家操作,使其应用局限于作为LDT(实验室自建检测)的CLIA实验室,限制了其在社区医院中的可及性以及在大型诊断网络中的部署。
在此,我们描述一种仅从明场成像数据估算单细胞生物物理特性的深度学习方法。具体而言,我们使用超过2000万对多参数测量作为真值标签,训练了一个基于向量量化变分自编码器(VQ-VAE)的模型。该训练数据将单细胞质量、体积、密度的测量值与从每个单细胞的在线明场图像中提取的形态学特征关联起来。该模型经过训练,以最小化仅从图像预测生物物理测量的误差,从而构建了一个简单成像可作为全面生物物理特征谱代理的框架。该生物物理推断模型能够从明场图像准确预测单细胞质量(RMSE < 2pg)和体积(RMSE < 15fL),R² > 0.95,超越了现有金标准仪器的性能。
当与我们的多参数平台一同部署时,生物物理推断使单细胞通量提高了50倍以上,同时保持测量的一致性。值得注意的是,仅基于图像预测的免疫细胞激活读数(此前已被证明可预测新辅助ICB反应)达到了95%的准确率,在我们经CLIA验证的工作流程中,在功能上等同于直接的生物物理测量。
这项工作确立了从明场显微镜推断定量生物物理特性的范式,架起了高内涵单细胞生物物理学与可扩展成像工作流程之间的桥梁。与依赖大型患者队列将高维特征与结局相关联的现有方法不同,我们的框架使用实验测量的生物物理参数作为可解释的中间量,将图像与患者反应联系起来。快速且廉价地获取的数百万个单细胞测量值提供了高效的训练基础。此外,该框架支持分层部署:核心实验室使用完整的多参数平台进行测量和模型训练,而外围站点部署低成本成像用于常规应用。
查看英文原文 English abstract
Single-cell biophysical measurements including mass, volume, density, and morphology provide a highly integrative readout of cellular state. We have previously demonstrated that these measurements enable rapid assessment of tumor cell drug response and immune cell functional fitness. As part of a CLIA-certified workflow with a two-day reporting turnaround, this approach enables clinically actionable decision support across diverse solid tumor malignancies and prediction of immune checkpoint blockade response. However, the complex instrumentation and expert operation required for these multiparametric measurements confine their use to CLIA laboratories as LDTs, limiting accessibility in community hospitals and deployment to large diagnostic networks.
Here we describe a deep learning approach that estimates single-cell biophysical properties from brightfield imaging data alone. Specifically, we trained a Vector Quantized Variational Autoencoder (VQ-VAE) based model using more than 20 million paired multiparametric measurements as ground truth. This training data linked measurements of single-cell mass, volume, density, and morphological features extracted from inline brightfield images for each individual cell. The model was trained to minimize prediction error for biophysical measurements from images alone, creating a framework where simple imaging can serve as a proxy for comprehensive biophysical profiling. The biophysical inference model accurately predicted single-cell mass (RMSE < 2pg) and volume (RMSE < 15fL) from brightfield images with an R² >0.95, exceeding the performance of existing gold-standard instrumentation.
When deployed alongside our multiparametric platform, biophysical inference increased single-cell throughput more than 50-fold while maintaining measurement concordance. Notably, image-only predictions of immune cell activation readout, previously shown to predict neoadjuvant ICB response, achieved 95% accuracy, functionally equivalent to direct biophysical measurements in our CLIA-validated workflow.
This work establishes a paradigm for inferring quantitative biophysical properties from brightfield microscopy, bridging high-content single-cell biophysics with scalable imaging workflows. Unlike existing approaches relying on large patient cohorts to correlate high-dimensional features with outcomes, our framework uses experimentally measured biophysical parameters as interpretable intermediates linking images to patient response. Millions of single-cell measurements acquired rapidly and inexpensively provide an efficient training foundation. Furthermore, the framework enables tiered deployment: core laboratories use the full multiparametric platform for measurements and model training, while peripheral sites deploy low-cost imaging for routine applications.
利益披露 Disclosure
N. Calistri,
Travera Employment, Stock Option, Patent.
S. Olcum,
Travera Employment, Stock, Stock Option, Patent.
R. Kimmerling,
Travera Employment, Stock, Stock Option, Patent.
S. Wasserman,
Travera Independent Contractor, Patent.
R. LaBella,
Travera Employment, Stock Option.
M. Vacha,
Travera Employment, Stock Option.
K. Katsis,
Travera Employment, Stock Option.
R. Aikins,
Travera Employment, Stock Option.
M. Ssozi,
Travera Employment, Stock Option.